908 Devices (MASS) Return on Capital Employed (2021 - 2026)
908 Devices' (MASS) quarterly Return on Capital Employed came in at 27.75% in Q1 2026, up 1069.0% year-on-year from 2.37% in Q1 2025, and down 10.12% on a QoQ basis from 25.2% in Q4 2025.
908 Devices (MASS) Return on Capital Employed (2021 - 2026) Analysis & Trends
908 Devices (MASS) has 6 years of Return on Capital Employed data on file, last reported at 27.75% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 1069.0% year-over-year to 27.75% in Q1 2026; TTM through Mar 2026 was 27.75%, a 1069.0% increase from a year earlier, with the FY2025 full-year figure at 28.02%, up 876.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 27.75%, down from 25.2% in the prior quarter.
- Over the last five years, Return on Capital Employed for MASS reached as high as 10.64% in Q1 2022 and fell as low as 41.08% in Q2 2025.
- Historically, Return on Capital Employed has averaged 24.65% across 5 years, with a median of 23.16% in 2023.
- On a YoY basis, Return on Capital Employed climbed as much as 1473 bps in 2025 and fell as far as 2139 bps in 2025.
- Year by year, Return on Capital Employed stood at 15.61% in 2022, then plunged by 50 bps to 23.34% in 2023, then slumped by 71 bps to 39.93% in 2024, then soared by 37 bps to 25.2% in 2025, then retreated by 10 bps to 27.75% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 27.75% in Q1 2026, 25.2% in Q4 2025, and 39.56% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 24.24% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 9.30% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 8.38% |
| 10 | 908 Devices | 264.17 Mn | 152.43 Mn | 6.88 Mn | -27.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.75% |
| Dec 31, 2025 | -25.20% |
| Sep 30, 2025 | -39.56% |
| Jun 30, 2025 | -41.08% |
| Mar 31, 2025 | -38.44% |
| Dec 31, 2024 | -39.93% |
| Sep 30, 2024 | -30.01% |
| Jun 30, 2024 | -19.68% |
| Mar 31, 2024 | -21.10% |
| Dec 31, 2023 | -23.34% |
| Sep 30, 2023 | -23.16% |
| Jun 30, 2023 | -21.32% |
| Mar 31, 2023 | -18.35% |
| Dec 31, 2022 | -15.61% |
| Sep 30, 2022 | -12.47% |
| Jun 30, 2022 | -11.42% |
| Mar 31, 2022 | -10.64% |
| Dec 31, 2021 | -11.10% |
| Sep 30, 2021 | -14.63% |
| Jun 30, 2021 | -11.68% |